A systematic methodology, able to assess risk and predict clinical safety and efficacy of Substances of Human Origin' (SoHO) has been developed. The model consists of a risk based approach taking into account factors such as novelty of the product, preparation process, clinical indication, and its technical complexity.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/intqhc/mzz048 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!